Table 1 Sociodemographic characteristics and clinical presentation of ART-naïve PLWH by gender at enrollment
From: Prevalence of hypertension among antiretroviral therapy naïve patients in Lagos, Nigeria
Characteristics | Overall (n = 10,426) | Female (n = 6886) | Male (n = 3540) | p-value |
|---|---|---|---|---|
aAge in years (± SD) | 36.41 (± 9.34) | 34.38 (± 8.61) | 40.37 (± 9.43) | < 0.001 |
Age groups in years, n (%) | < 0.001 | |||
18 – 24 | 652 (6.3) | 532 (7.7) | 120 (3.4) | |
25—49 | 8756 (84.0) | 5899 (85.7) | 2857 (80.7) | |
≥ 50 | 1018 (9.7) | 455 (6.6) | 563 (15.9) | |
Educational Status, n (%) | < 0.001 | |||
None | 507 (4.9) | 397 (5.8) | 110 (3.1) | |
Primary | 1941 18.8) | 1261 (18.5) | 680 (19.4) | |
Secondary | 4485 (43.5) | 2960 (43.5) | 1525 (43.5) | |
Tertiary | 3380 (32.8) | 2191 (32.2) | 1189 (34.0) | |
Occupation, n (%) | < 0.001 | |||
Unemployed | 1206 (11.6) | 941 (13.7) | 265 (7.5) | |
Employed | 9093 (87.6) | 5890 (85.8) | 3203 (90.9) | |
Retired | 87 (0.8) | 30 (0.5) | 57 (1.6) | |
Marital status, n (%) | < 0.001 | |||
Single | 2986 (28.6) | 1976 (28.7) | 1010 (28.5) | |
Married | 5879 (56.4) | 3676 (53.4) | 2203 (62.3) | |
Separated | 633 (6.1) | 764 (11.1) | 164 (4.6) | |
Widowed | 928 (8.9) | 470 (6.8) | 163 (4.6) | |
Alcohol intake, n (%) | < 0.001 | |||
Never | 7339 (77.3) | 5416 (86.4) | 1923 (59.7) | |
Light and Moderate | 1978 (20.8) | 833 (13.3) | 1145 (35.6) | |
Heavy | 172 (1.6) | 20 (0.3) | 152 (4.7) | |
Co-morbidity, n (%) | ||||
Tuberculosis | 581 (5.6) | 306 (4.4) | 275 (7.8) | < 0.001 |
Diabetes Mellitus | 80 (0.8) | 33 (0.05) | 47 (1.3) | < 0.001 |
Renal disease | 35 (0.3) | 16 (0.2) | 19 (0.5) | 0.001 |
Hypertension | 358 (3.4) | 196 (2.8) | 162 (4.6) | < 0.001 |
Mean Systolic BP (± SD) | 114.20 (± 19.91) | 112 02 (± 19.22) | 118.45 (± 20.53) | < 0.001 |
Mean Diastolic BP (± SD) | 73.20 (± 12.93) | 72.34 (± 12.67) | 74.88 (± 13.26) | < 0.001 |
BMI categories (kg/m2), n (%) | ||||
Median (25th – 75th percentiles) | 23.12 (20.28 – 26.63) | 23.44 (20.32 – 27.12) | 22.58 (20.18 – 25.54) | |
Underweight/Normal | 5735 (64.8) | 3606 (61.7) | 2129 (70.6) | 0.009 |
Overweight/Obese | 3122 (35.2) | 2237 (38.3) | 885 (29.4) | |
WHO Stage, n (%) | < 0.001 | |||
1 | 1347 (19.8) | 1007 (22.5) | 340 (14.6) | |
2 | 2471 (36.4) | 1683 (37.7) | 788 (33.8) | |
3 | 2287 (33.6) | 1387 (31.0) | 900 (38.6) | |
4 | 693 (10.2) | 393 (8.8) | 300 (12.8) | |
Viral Load (copies/ml), n (%) | < 0.001 | |||
≤ 1000 | 2458 (28.9) | 1677 (29.5) | 781 (27.9) | |
1001 – 100,000 | 3004 (35.4) | 2197 (38.6) | 807 (28.8) | |
≥ 100,001 | 3029 (35.7) | 1814 (31.9) | 1215 (43.3) | |
CD4 count (cells/μL), n (%) | < 0.001 | |||
≤ 200 | 4483 (44.8) | 2739 (41.4) | 1744 (51.4) | |
201 – 499 | 3985 (39.8) | 2711 (41.0) | 1274 (37.6) | |
≥ 500 | 1537 (15.4) | 1164 (17.6) | 373 (11.0) |